Advaxis, Inc. (ADXS)

USD 0.03

(0.0%)

Inventory Summary of Advaxis, Inc.

  • Advaxis, Inc.'s latest annual inventory in 2023 was - USD , up 100.0% from previous year.
  • Advaxis, Inc.'s latest quarterly inventory in 2023 FY was - USD , up 100.0% from previous quarter.
  • Advaxis, Inc. reported annual inventory of -234 Thousand USD in 2022, up 65.64% from previous year.
  • Advaxis, Inc. reported annual inventory of -681 Thousand USD in 2021, down -150.86% from previous year.
  • Advaxis, Inc. reported quarterly inventory of - USD for 2023 Q2, down -100.0% from previous quarter.
  • Advaxis, Inc. reported quarterly inventory of 108 Thousand USD for 2023 Q1, down -80.04% from previous quarter.

Annual Inventory Chart of Advaxis, Inc. (2023 - 2002)

Historical Annual Inventory of Advaxis, Inc. (2023 - 2002)

Year Inventory Inventory Growth
2023 - USD 100.0%
2022 -234 Thousand USD 65.64%
2021 -681 Thousand USD -150.86%
2020 1.33 Million USD 1513.25%
2019 83 Thousand USD 104.99%
2018 -1.66 Million USD 0.0%
2017 - USD -100.0%
2016 5.1 Million USD 368.87%
2015 1.08 Million USD -5.15%
2014 1.14 Million USD 0.0%
2013 - USD -100.0%
2012 10.48 Million USD 27876.79%
2011 37.47 Thousand USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%

Peer Inventory Comparison of Advaxis, Inc.

Name Inventory Inventory Difference
Eiger BioPharmaceuticals, Inc. 1.55 Million USD 100.0%
Nanobac Pharmaceuticals, Incorporated 10.3 Thousand USD 100.0%
SQZ Biotechnologies Company - USD NaN%
Evofem Biosciences, Inc. 1.69 Million USD 100.0%
Santhera Pharmaceuticals Holding AG 2.15 Million USD 100.0%
Mesoblast Limited 1.00 USD 100.0%
Propanc Biopharma, Inc. - USD NaN%
Genus plc 89.4 Million USD 100.0%
VioQuest Pharmaceuticals, Inc. - USD NaN%
CNBX Pharmaceuticals Inc. -94.61 Thousand USD 100.0%
Marizyme, Inc. 24.85 Thousand USD 100.0%
ContraFect Corporation - USD NaN%
Nymox Pharmaceutical Corporation 16 Thousand USD 100.0%
PsyBio Therapeutics Corp. - USD NaN%
Sienna Biopharmaceuticals, Inc. - USD NaN%
RegeneRx Biopharmaceuticals, Inc. - USD NaN%
Intellipharmaceutics International Inc. 1.00 USD 100.0%
AXIM Biotechnologies, Inc. - USD NaN%
MultiCell Technologies, Inc. - USD NaN%
Accustem Sciences Inc. - USD NaN%
RVL Pharmaceuticals plc 784 Thousand USD 100.0%
EV Biologics, Inc. - USD NaN%
Q BioMed Inc. - USD NaN%
Emmaus Life Sciences, Inc. 1.71 Million USD 100.0%
Neon Bloom, Inc. 7938.00 USD 100.0%
Mosaic ImmunoEngineering Inc. - USD NaN%
Biomind Labs Inc. - USD NaN%
TetraLogic Pharmaceuticals Corporation - USD NaN%
Pharming Group N.V. 56.76 Million USD 100.0%
Oncotelic Therapeutics, Inc. - USD NaN%
Skye Bioscience, Inc. - USD NaN%
Therapeutic Solutions International, Inc. 22.57 Thousand USD 100.0%
THC Farmaceuticals, Inc. - USD NaN%
Arch Therapeutics, Inc. 1.36 Million USD 100.0%
IMV Inc. 2.00 USD 100.0%
Acro Biomedical Co., Ltd. 12 Thousand USD 100.0%
Curative Biotechnology, Inc. -115.62 Thousand USD 100.0%
GB Sciences, Inc. - USD NaN%
Alpha Cognition Inc. 90.41 Thousand USD 100.0%
HST Global, Inc. - USD NaN%
CSL Limited 5.96 Billion USD 100.0%
Halberd Corporation - USD NaN%
Enzolytics Inc. - USD NaN%
Resverlogix Corp. 2.37 Million USD 100.0%
Affymax, Inc. - USD NaN%
SYBLEU INC - USD NaN%
Nuo Therapeutics, Inc. 209.58 Thousand USD 100.0%
argenx SE 310.55 Million USD 100.0%
MetaStat, Inc. - USD NaN%
Northwest Biotherapeutics, Inc. - USD NaN%
Enzon Pharmaceuticals, Inc. - USD NaN%
Arno Therapeutics, Inc. - USD NaN%
RespireRx Pharmaceuticals Inc. - USD NaN%
GeneThera, Inc. - USD NaN%
Inhibitor Therapeutics, Inc. - USD NaN%
AVAX Technologies, Inc. 11.52 Thousand USD 100.0%
Zenith Capital Corp. 3.00 USD 100.0%
Genscript Biotech Corporation 53.33 Million USD 100.0%
Ember Therapeutics, Inc. - USD NaN%
Anthera Pharmaceuticals, Inc. - USD NaN%
Sigyn Therapeutics, Inc. 50 Thousand USD 100.0%
WPD Pharmaceuticals Inc. 0.25 USD 100.0%
American Oriental Bioengineering, Inc. 20.57 Million USD 100.0%
Provectus Biopharmaceuticals, Inc. - USD NaN%
Adynxx, Inc. - USD NaN%
Helix BioMedix, Inc. - USD NaN%
GlobeStar Therapeutics Corporation - USD NaN%
VitaSpring Biomedical Co. Ltd. - USD NaN%
Capstone Therapeutics Corp. 12.83 Million USD 100.0%
Cotinga Pharmaceuticals Inc. 0.98 USD 100.0%
BioStem Technologies, Inc. 658.67 Thousand USD 100.0%
ONE Bio Corp. 4.5 Million USD 100.0%
Reve Technologies, Inc. - USD NaN%
Burzynski Research Institute, Inc. - USD NaN%
Wesana Health Holdings Inc. 1.00 USD 100.0%
Agentix Corp. - USD NaN%
LadRx Corporation - USD NaN%
Cell Source, Inc. - USD NaN%
ProtoKinetix, Incorporated - USD NaN%
Regen BioPharma, Inc. - USD NaN%
Regen BioPharma, Inc. - USD NaN%
NovAccess Global Inc. - USD NaN%
Endonovo Therapeutics, Inc. - USD NaN%
Itoco Inc. - USD NaN%
Rasna Therapeutics, Inc. -20.67 Thousand USD 100.0%
Pathfinder Cell Therapy, Inc. - USD NaN%
Kadimastem Ltd - USD NaN%
Oncology Pharma Inc. - USD NaN%
Institute of Biomedical Research Corp. - USD NaN%
CytoDyn Inc. - USD NaN%
Claritas Pharmaceuticals, Inc. - USD NaN%
NDT Pharmaceuticals Inc. - USD NaN%
Mobile Lads Corp. - USD NaN%
NanoSphere Health Sciences Inc. -8.71 USD 100.0%
Qrons Inc. - USD NaN%
Alseres Pharmaceuticals, Inc. - USD NaN%
Advanced Proteome Therapeutics Corporation - USD NaN%
Nascent Biotech, Inc. - USD NaN%
Rebus Holdings, Inc. - USD NaN%
ImmunoCellular Therapeutics, Ltd. - USD NaN%
International Stem Cell Corporation 1.26 Million USD 100.0%
Bioxytran, Inc. - USD NaN%
GlobeImmune, Inc. - USD NaN%
Predictive Technology Group, Inc. - USD NaN%
ProText Mobility, Inc. 15 Million USD 100.0%
Cardax, Inc. - USD NaN%
VG Life Sciences Inc. - USD NaN%
Kaleido Biosciences, Inc. - USD NaN%
Adhera Therapeutics, Inc. - USD NaN%
RenovaCare, Inc. - USD NaN%
Regnum Corp. - USD NaN%
Innovation Pharmaceuticals Inc. - USD NaN%
Neutra Corp. - USD NaN%
Windtree Therapeutics, Inc. - USD NaN%
PureTech Health plc - USD NaN%
Coeptis Therapeutics, Inc. - USD NaN%
IXICO plc 1.00 USD 100.0%
IntelGenx Technologies Corp. 71 Thousand USD 100.0%
Gelesis Holdings, Inc. 6.86 Million USD 100.0%
CSL Limited 5.96 Billion USD 100.0%
Cellectis S.A. 1.00 USD 100.0%